Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272514 · ClinicalTrials.gov registry record
Impact of Hypoxia on Resting and Exertional Right Ventricular Performance
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 10
- Enrollment target
NCT05272514: Completed study, sponsored by University of Colorado, Denver.
NCT05272514 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05272514 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand how hypoxia (low oxygen) affects resting and exertional right ventricular function in healthy individuals.
Primary Outcome
End-systolic elastance (Ees) in mmHg/mL
Interventions
- OTHER Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2022-12-15 |
What the finished NCT05272514 record still lists
NCT05272514 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Hypoxia is the first listed.
NCT05272514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05272514 about?
NCT05272514 is a clinical study titled "Impact of Hypoxia on Resting and Exertional Right Ventricular Performance". The purpose of this study is to better understand how hypoxia (low oxygen) affects resting and exertional right ventricular function in healthy individuals.
What is the current status of trial NCT05272514?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-04-15. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05272514?
The interventions under investigation include: Hypoxia (OTHER).
Who is sponsoring clinical trial NCT05272514?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI